Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic AF: Results of the FORWARD Trial

Summary

According to the results from the Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation [FORWARD; NCT00597220], pharmacological supplementation with n-3 polyunsaturated fatty acids (PUFA) does not reduce recurrent atrial fibrillation.

  • Arrhythmias
  • Cardiology Clinical Trials
View Full Text